131 related articles for article (PubMed ID: 37338326)
1. Macrophage-Cancer Hybrid Membrane-Camouflaged Nanoplatforms for HIF-1α Gene Silencing-Enhanced Sonodynamic Therapy of Glioblastoma.
Li Y; Liu Y; Xu J; Chen D; Wu T; Cao Y
ACS Appl Mater Interfaces; 2023 Jul; 15(26):31150-31158. PubMed ID: 37338326
[TBL] [Abstract][Full Text] [Related]
2. Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of Glioblastoma.
Wu T; Liu Y; Cao Y; Liu Z
Adv Mater; 2022 Apr; 34(15):e2110364. PubMed ID: 35133042
[TBL] [Abstract][Full Text] [Related]
3. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
4. Atypical induction of HIF-1α expression by pericellular Notch1 signaling suffices for the malignancy of glioblastoma multiforme cells.
Lee J; Kim E; Chong K; Ryu SW; Kim C; Choi K; Kim JH; Choi C
Cell Mol Life Sci; 2022 Oct; 79(10):537. PubMed ID: 36183290
[TBL] [Abstract][Full Text] [Related]
5. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
[TBL] [Abstract][Full Text] [Related]
6. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
8. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo.
Fiorenzo P; Mongiardi MP; Dimitri D; Cozzolino M; Ferri A; Montano N; Trevisi G; Maira G; Battistini L; Falchetti ML; Levi A; Pallini R
Int J Oncol; 2010 Apr; 36(4):785-91. PubMed ID: 20198320
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells.
Boso D; Rampazzo E; Zanon C; Bresolin S; Maule F; Porcù E; Cani A; Della Puppa A; Trentin L; Basso G; Persano L
Theranostics; 2019; 9(17):4860-4877. PubMed ID: 31410187
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
[TBL] [Abstract][Full Text] [Related]
12. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
[TBL] [Abstract][Full Text] [Related]
13. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
14. Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α.
Zhang Y; Liu Q; Wang F; Ling EA; Liu S; Wang L; Yang Y; Yao L; Chen X; Wang F; Shi W; Gao M; Hao A
J Pineal Res; 2013 Sep; 55(2):121-30. PubMed ID: 23551342
[TBL] [Abstract][Full Text] [Related]
15. Casein kinase 1α 1 is involved in the progression of glioblastoma through HIF-1α-mediated autophagy.
Nie W; Luo X; Lu D; Yuan P; Liu B; Xu H; Ye M
J Neurophysiol; 2022 Oct; 128(4):910-918. PubMed ID: 36102564
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.
Staab A; Fleischer M; Loeffler J; Said HM; Katzer A; Plathow C; Einsele H; Flentje M; Vordermark D
Strahlenther Onkol; 2011 Apr; 187(4):252-9. PubMed ID: 21437769
[TBL] [Abstract][Full Text] [Related]
17. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
[TBL] [Abstract][Full Text] [Related]
18. Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells.
Shen SH; Kwan AL; Chen YY; Wang ZX
Neurol Sci; 2013 Mar; 34(3):365-71. PubMed ID: 22454035
[TBL] [Abstract][Full Text] [Related]
19. IDH1-R132H Suppresses Glioblastoma Malignancy through FAT1-ROS-HIF-1α Signaling.
Li LC; Zhang M; Feng YK; Wang XJ
Neurol India; 2020; 68(5):1050-1058. PubMed ID: 33109851
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
